INBX Stock Analysis: Buy, Sell, or Hold?
INBX - Inhibrx Biosciences, Inc. Common Stock
$97.58
2.64 (2.78%)
▲
5d:
+2.38%
30d:
+4.22%
90d:
+45.53%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When INBX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: INBX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: INBX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: INBX is currently trading at $97.58, which is considered slightly high relative to its 30-day fair value range of $90.32 to $99.74.
Technical Outlook: Technically, INBX is in a uptrend. Immediate support is located at $86.40, while resistance sits at $103.79.
Market Sentiment: INBX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $277.50 (+184.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INBX is in a uptrend. Immediate support is located at $86.40, while resistance sits at $103.79.
Market Sentiment: INBX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $277.50 (+184.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$90.32 -
$99.74
Company Quality Score
52/100
(HOLD)
Options IV Signal
34th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- NEUTRAL: Options fairly priced (IV 34th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 184.4% below Wall St target ($277.50)
Trading Range Analysis
30-Day Trading Range
$90.32 -
$99.74
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$12.32
(12.6%)
Support & Resistance Levels
Support Level
$86.40
Resistance Level
$103.79
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.49
Wall Street Target
$277.50
(+184.4%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 02, 2026 10:47 PM ET
Data refreshes hourly during market hours. Next update: 11:47 PM
Data refreshes hourly during market hours. Next update: 11:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 63 BUY |
Advanced INBX Option Strategies
Professional options setups generated by AI based on today's INBX price and gamma walls.
